You just read:

Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Programme for Investigational Once-Daily HIV Integrase Inhibitor

News provided by

Shionogi-ViiV Healthcare LLC

Oct 21, 2010, 04:00 ET